Faculty:
John A. Hovanesian MD, FACS
Clinical Faculty
UCLA Jules Stein Eye Institute
Los Angeles, CA
Private Practice
Harvard Eye Associates
Laguna Hills, CA
Reviewer:
Terry Kim, MD
Ronald Codario, MD, FACP, FNLA, RPVI, CHCP
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Faculty member reports the following relationship(s)which are accurate at the time of original content release (August 22, 2016):
John A. Hovanesian MD, FACS
Consulting Fees: 1-800-DOCTORS, Abbott Medical Optics, Alcon Laboratories, Inc., Allegro Ophthalmics, Allergan, Inc., BlephEx, EssexBio, Glaukos Corporation, Guardion Health Sciences, Halozyme, IOP, NextGen Healthcare, Ocular Therapeutix, Omeros, Optos, ReVision Optics, Sarentis Ophthalmics, Shire, TearScience, Valeant
Medical Advisory Board: 1-800-DOCTORS, Abbott Medical Optics, Bausch + Lomb, Inc., BlephEx, EssexBio, Glaukos Corporation, Guardion Health Sciences, Halozyme, IOP, MDbackline, Ocular Therapeutix, Omeros, ReVision Optics, Shire, Sight Sciences, TearScience, Valeant
Equity Interest: Alicia Surgery Center, Allegro Ophthalmics, Allergan, Inc., Guardion Health Sciences, Harvard Eye Associates, Harvard Hearing, MDbackline, Ocular Therapeutix, Sight Sciences, South Orange County Outpatient Surgery Center
Research Funds: Abbott Medical Optics, Alcon Laboratories, Inc., Allergan, Inc., Bausch + Lomb, Inc., Glaukos Corporation, IOP, Ocular Therapeutix, Omeros, ReVision Optics, Shire, TearScience, Valeant
Royalty: SLACK Books, TLC
Reviewers report the following relationship(s):
Terry Kim, MD
Consulting Fee: Acucela, Acuity Advisors, Aerie, Alcon, Allergan/Actavis, Bausch + Lomb/Valeant, CoDa Therapeutics, Foresight, Kala, NovaBay, Ocular Systems, Ocular Therapeutix, Oculeve, Omeros, Powervision, Presbyopia, Shire, Stealth BioTherapeutics, TearLab, TearScience
Speakers Bureau: Alcon, Allergan, Bausch + Lomb/Valeant, Omeros, Shire
Ownership Interest: CoDa Therapeutics, NovaBay, Ocular Therapeutix, Omeros, Powervision, Presbyopia
Ronald Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.